Visit COVID-19 resources

[Skip to Content]

Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab – (Eye 30, 79 (January 2016))

7 January 2016

This news item is available to RCOphth members only, please log in below to access.

Members Login